Second tumors in children with hematological malignancies
Background. Hemoblastoses treatment success in children made it possible to cure the vast majority of patients. The follow-up period exceeds tens of years, during which the problem of second tumors (ST) becomes urgent. The objective of the study was to characterize ST in patients who underwent a ma...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-04-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/462 |
| _version_ | 1826557133085212672 |
|---|---|
| author | N. A. Susuleva T. T. Valiev N. S. Martynova S. N. Mikhaylova |
| author_facet | N. A. Susuleva T. T. Valiev N. S. Martynova S. N. Mikhaylova |
| author_sort | N. A. Susuleva |
| collection | DOAJ |
| description | Background. Hemoblastoses treatment success in children made it possible to cure the vast majority of patients. The follow-up period exceeds tens of years, during which the problem of second tumors (ST) becomes urgent. The objective of the study was to characterize ST in patients who underwent a malignant tumor of hematopoietic and lymphoid tissues at the age of 0 to 18 years.Materials and methods. The study included 64 patients with ST development in the period from 1 to 38 years.Results. Most frequently ST developed after treatment of Hodgkin's lymphoma (45.3 %) and acute lymphoblastic leukemia (35.9 %), supported by high cumulative doses of alkylating agents and radiation therapy. Among STs, in 35.9 % of cases, thyroid cancer was diagnosed, in 10.9 % - acute leukemia, in 9.4 % - tumors of the central nervous system. The results of ST treatment are significantly worse than those of primary tumors. Thus, of 64 patients with ST, 46 (71.9 %) are alive, death from ST progression was noted in 18 (28.1 %) cases.Conclusion. Improvement of modern treatment protocols aimed at reducing the indications for radiation therapy and cumulative doses of alkylating agents, along with the development of effective follow-up programs for children cured of hematological malignancies, will probably help reduce the ST incidence. |
| first_indexed | 2024-04-09T20:23:58Z |
| format | Article |
| id | doaj.art-1e7cdaf415d74d2ca9a084c855630e0c |
| institution | Directory Open Access Journal |
| issn | 1818-8346 2413-4023 |
| language | Russian |
| last_indexed | 2025-03-14T08:23:45Z |
| publishDate | 2021-04-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Онкогематология |
| spelling | doaj.art-1e7cdaf415d74d2ca9a084c855630e0c2025-03-02T13:07:12ZrusABV-pressОнкогематология1818-83462413-40232021-04-01161364610.17650/1818-8346-2021-16-1-36-46380Second tumors in children with hematological malignanciesN. A. Susuleva0T. T. Valiev1N. S. Martynova2S. N. Mikhaylova3Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaRussian Medical Academy of Continuing Professional Education, Ministry of Health of Russia; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaRussian Medical Academy of Continuing Professional Education, Ministry of Health of Russia; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaBackground. Hemoblastoses treatment success in children made it possible to cure the vast majority of patients. The follow-up period exceeds tens of years, during which the problem of second tumors (ST) becomes urgent. The objective of the study was to characterize ST in patients who underwent a malignant tumor of hematopoietic and lymphoid tissues at the age of 0 to 18 years.Materials and methods. The study included 64 patients with ST development in the period from 1 to 38 years.Results. Most frequently ST developed after treatment of Hodgkin's lymphoma (45.3 %) and acute lymphoblastic leukemia (35.9 %), supported by high cumulative doses of alkylating agents and radiation therapy. Among STs, in 35.9 % of cases, thyroid cancer was diagnosed, in 10.9 % - acute leukemia, in 9.4 % - tumors of the central nervous system. The results of ST treatment are significantly worse than those of primary tumors. Thus, of 64 patients with ST, 46 (71.9 %) are alive, death from ST progression was noted in 18 (28.1 %) cases.Conclusion. Improvement of modern treatment protocols aimed at reducing the indications for radiation therapy and cumulative doses of alkylating agents, along with the development of effective follow-up programs for children cured of hematological malignancies, will probably help reduce the ST incidence.https://oncohematology.abvpress.ru/ongm/article/view/462hematological malignanciessecond tumorchemotherapyradiation therapychildren |
| spellingShingle | N. A. Susuleva T. T. Valiev N. S. Martynova S. N. Mikhaylova Second tumors in children with hematological malignancies Онкогематология hematological malignancies second tumor chemotherapy radiation therapy children |
| title | Second tumors in children with hematological malignancies |
| title_full | Second tumors in children with hematological malignancies |
| title_fullStr | Second tumors in children with hematological malignancies |
| title_full_unstemmed | Second tumors in children with hematological malignancies |
| title_short | Second tumors in children with hematological malignancies |
| title_sort | second tumors in children with hematological malignancies |
| topic | hematological malignancies second tumor chemotherapy radiation therapy children |
| url | https://oncohematology.abvpress.ru/ongm/article/view/462 |
| work_keys_str_mv | AT nasusuleva secondtumorsinchildrenwithhematologicalmalignancies AT ttvaliev secondtumorsinchildrenwithhematologicalmalignancies AT nsmartynova secondtumorsinchildrenwithhematologicalmalignancies AT snmikhaylova secondtumorsinchildrenwithhematologicalmalignancies |